Addex Therapeutics (ADXN) Times Interest Earned (2019 - 2026)
Addex Therapeutics (ADXN) posted Times Interest Earned of $0.0 for Q1 2026, down 100.0% sequentially from $852.11 in Q3 2025, and down 31.81% YoY from $0.0 in Q1 2025.
Addex Therapeutics (ADXN) Times Interest Earned (2019 - 2026) Analysis & Trends
Addex Therapeutics has reported Times Interest Earned for 8 years, with the latest figure at $0.0 in Q1 2026.
- Quarterly Times Interest Earned fell 31.81% year-over-year to $0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.0 (down 47.34% YoY) and the FY2025 annual result came in at -$181.04, up 76.69% from the prior year.
- Times Interest Earned fell to $0.0 in Q1 2026 per ADXN's latest filing, from $852.11 in the prior quarter.
- Over five years, Times Interest Earned peaked at $852.11 in Q3 2025 and troughed at -$1040.9 in Q2 2024.
- A 5-year average of $47.95 and a median of $0.0 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned plunged 37134.91% in 2024, then surged 1059046697.32% in 2025.
- Over 5 years, Times Interest Earned stood at -$61.54 in 2022, then surged by 100.0% to -$0.0 in 2023, then sank by 110.48% to -$0.0 in 2024, then jumped by 239179060.0% to $852.11 in 2025, then sank by 100.0% to $0.0 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.0, $852.11, and $125.75 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | 180.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Sep 30, 2025 | 852.11 |
| Jun 30, 2025 | 125.75 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -1,040.88 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -2.80 |
| Mar 31, 2023 | 39.62 |
| Dec 31, 2022 | -61.54 |
| Sep 30, 2022 | 652.72 |
| Jun 30, 2022 | -54.88 |
| Mar 31, 2022 | 257.10 |
| Dec 31, 2021 | -132.89 |
| Sep 30, 2021 | 36.73 |
| Jun 30, 2021 | -196.46 |
| Mar 31, 2021 | 151.79 |